Junsang Yoo

Dr. Junsang Yoo


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 August 2022 in Acta Biomaterialia
Verified
Journal Article
Closed access
SLSungwoo Lee
Sungwoo Lee
HSHyun Soo Shim
Hyun Soo Shim
HPHyeok Ju Park
Hyeok Ju Park
YCYujung Chang
Yujung Chang
YHYoung-Eun Han
Young-Eun Han
JYJunsang Yoo
Junsang Yoo

20 July 2018 in Molecular Neurobiology
Verified
Journal Article
Closed access
PDF file
YKYu-Kang Kim
Yu-Kang Kim
ALAhreum Lee
Ahreum Lee
JKJongpil Kim
Jongpil Kim
JYJunsang Yoo
Junsang Yoo
CPChan Yong PARK
Chan Yong PARK
HPHi-Joon Park
Hi-Joon Park

21 November 2025 in Advanced Science
Verified
Journal Article
Open access
YCYujung Chang
Yujung Chang
YNYongwoo Na
Yongwoo Na
HIHyeonjoo Im
Hyeonjoo Im
GYGaram Yang
Garam Yang
SYSeungseon Yang
Seungseon Yang
JYJunsang Yoo
Junsang Yoo
Parkinson's disease (PD) is a progressive neurodegenerative disorder characterized by the loss of dopaminergic neurons (DN) in the substantia nigra and disruption of cellular maintenance. Here, we demonstrate that NDST3‐mediated epigenetic reprogramming halts neuronal degeneration and restores motor function in an animal model of PD. Following NDST3 administration, the DN and its associated circuits in the substantia nigra and striatum showed marked revitalization, accompanied by a considerable alleviation of PD‐like motor deficits. Integrative single‐cell and spatial RNA sequencing with CUT&RUN revealed that NDST3‐driven reactivation of pathways is linked to neuronal survival, synaptic integrity, and steering of compromised cells toward a resilient phenotype. By recalibrating the epigenetic landscape, NDST3 promotes cellular maintenance and functional recovery in key motor circuits. These findings highlight NDST3's therapeutic potential as an epigenetic modulator of PD. These findings provide insights into the mechanisms underlying neuronal revitalization and highlight the potential of NDST3 as a novel agent for restoring brain function in neurodegenerative conditions.